Quick Answer
BRAINSTORM CELL THERAPEUTICS INC. reported Total Assets of $1.02 million for fiscal year 2025.
BRAINSTORM CELL THERAPEUTICS INC. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $1.02M | -44.2% |
| 2024 | $1.83M | -56.5% |
| 2023 | $4.21M | -50.2% |
| 2022 | $8.45M | -71.1% |
| 2021 | $29.28M | -42.9% |
| 2020 | $51.26M | +684.5% |
| 2019 | $6.53M | -41.8% |
| 2018 | $11.23M | -1.7% |
| 2017 | $11.42M | +6.1% |
| 2016 | $10.77M | -37.0% |
| 2015 | $17.08M | +72.3% |
| 2014 | $9.91M | +109.7% |
| 2013 | $4.73M | -8.0% |
| 2012 | $5.14M | +87.2% |
| 2011 | $2.74M | +152.0% |
| 2010 | $1.09M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.38M | -31.9% | -46.2% |
| June 30, 2025 | $2.57M | -54.8% | -28.1% |
| March 31, 2025 | $3.57M | +6.7% | +94.9% |
| December 31, 2024 | $1.83M | -56.5% | -9.5% |
| September 30, 2024 | $2.02M | -64.4% | -64.4% |
| June 30, 2024 | $5.68M | -1.1% | +69.7% |
| March 31, 2024 | $3.35M | -57.5% | -20.4% |
| December 31, 2023 | $4.21M | -50.2% | -25.9% |
- BRAINSTORM CELL THERAPEUTICS INC. showed a decrease of -44.2% in Total Assets compared to the prior fiscal year.
- Over the 2010–2025 period, BRAINSTORM CELL THERAPEUTICS INC.’s total assets has declined by 6.2% (from $1.09 million to $1.02 million).
- The most recent figure is from BRAINSTORM CELL THERAPEUTICS INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: